{"id":"danshen-dripping-pill","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding or bruising"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The herbal formulation contains active compounds from Salvia miltiorrhiza (danshen) that enhance microcirculation, reduce blood viscosity, and prevent thrombotic events. It works through multiple pathways including antiplatelet effects, anticoagulation, and improvement of myocardial perfusion, making it useful in cardiovascular conditions characterized by blood stasis.","oneSentence":"Danshen dripping pill improves blood circulation and reduces blood stasis by promoting vasodilation and inhibiting platelet aggregation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:32:20.646Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Angina pectoris"},{"name":"Myocardial infarction prevention"},{"name":"Coronary artery disease"}]},"trialDetails":[{"nctId":"NCT07041359","phase":"PHASE4","title":"Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment","status":"RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2025-08-18","conditions":"Coronary Arterial Disease (CAD)","enrollment":120},{"nctId":"NCT06727890","phase":"PHASE4","title":"Compound Danshen Dripping Pill for Diabetic Microvascular Angina","status":"NOT_YET_RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2025-01-01","conditions":"Diabetic Microvascular Angina","enrollment":162},{"nctId":"NCT06092736","phase":"PHASE4","title":"Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)","status":"RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2018-12-18","conditions":"Microvascular Angina","enrollment":100},{"nctId":"NCT05295329","phase":"NA","title":"Effect of Compound Danshen Dripping Pills on Diabetic Patients With Coronary Microcirculation Disturbance","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2022-04-01","conditions":"Diabetes","enrollment":120},{"nctId":"NCT03270787","phase":"PHASE1, PHASE2","title":"Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness","status":"COMPLETED","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2016-06-24","conditions":"Acute Mountain Sickness","enrollment":58},{"nctId":"NCT02388984","phase":"PHASE3","title":"Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy","status":"UNKNOWN","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2013-05","conditions":"Non-proliferative Diabetic Retinopathy","enrollment":480},{"nctId":"NCT01659580","phase":"PHASE3","title":"Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina","status":"COMPLETED","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2012-08","conditions":"Angina Pectoris","enrollment":1004},{"nctId":"NCT01679028","phase":"PHASE1","title":"Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in Japanese","status":"COMPLETED","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2012-08","conditions":"Healthy","enrollment":20},{"nctId":"NCT01825759","phase":"PHASE4","title":"Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function","status":"UNKNOWN","sponsor":"West China Hospital","startDate":"2013-01","conditions":"Coronary Heart Disease, Essential Hypertension","enrollment":200}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"LUNG DISORDER"},{"count":1,"reaction":"MYALGIA"},{"count":1,"reaction":"PNEUMONIA"},{"count":1,"reaction":"RHABDOMYOLYSIS"}],"_approvalHistory":[],"publicationCount":61,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["compound danshen dripping pill"],"phase":"marketed","status":"active","brandName":"danshen dripping pill","genericName":"danshen dripping pill","companyName":"West China Hospital","companyId":"west-china-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Danshen dripping pill, also known as T89, has been studied in clinical trials for conditions such as angina pectoris, coronary arterial disease, and microvascular angina. The exact mechanism of action of danshen dripping pill is not specified in the provided facts, but it has been used in various studies, including a Phase III trial for stable angina prevention and treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}